1Beatrice T, Ina H, Claudia R et al. Vaccination with Mage-3A1 peptide - pulsed mature, monocyte- derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma[J] .J Exp Med, 1999;190(11) :1669- 1678.
2Kugler A, Stuhler G, Walden P et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids[J]. Nat Med, 2000;6(3):332- 336.
3Sadanaga N, Nagashima H, Mashino K et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas[J]. Clin Cancer Res, 2001;7(8) :2277 - 2281.
4Tjoa BA, Lodge PA, Salgaller ML et al. Dendritic cell - based immunotherapy for prostate cancer [ J ]. CA Cancer J Clin,1999;49(2) :117 - 128.
5Patrick AB, Jami KB, Jan CB et al. Priming Tissue - specific Cellular Immunity in a Phase I Trim of Autologous Dendritic Cells for Prostate Cancer[J]. Clin Cancer Res[J] .2000;6(6):2175 - 2182.
